| Financial Year |
March 31 2023 |
| Monetary Funds |
4,417,429.48 |
| Held-for-trading Financial Assets |
19,739,547.67 |
| Notes Receivable |
6,121,493.46 |
| Accounts Receivable |
37,489,723.52 |
| Advances to Suppliers |
2,824,863.31 |
| Other Receivables |
1,171,067.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
26,321,407.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
928,596.88 |
| Total Current Assets |
105,251,784.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
36,173,788.49 |
| Under-construction Projects |
795,734.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,205,373.05 |
| R&D expenses |
-- |
| Goodwill |
4,442,515.82 |
| Long-Term Deferred and Prepaid Expenses |
11,383,515.36 |
| Deferred Income Tax Assets |
789,588.53 |
| Other Non-Current Assets |
507,391,324.71 |
| Sub-Total of Non-Current Assets |
569,433,323.62 |
| Total Assets |
674,685,108.24 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,000,000.00 |
| Accounts Payable |
12,276,194.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,408,671.26 |
| Taxes Payable |
1,212,905.91 |
| Interest Payable |
86,195.67 |
| Dividend Payable |
1,655,188.46 |
| Other payables |
5,332,730.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,527,239.46 |
| Other Current Liabilities |
6,576,552.87 |
| Sub-Total of Current Liabilities |
34,834,750.87 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,614,654.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,925,325.79 |
| Total Liabilities |
41,760,076.66 |
| Paid-In Capital(Or Share Stock) |
188,020,508.00 |
| Capital Surplus |
447,933,518.83 |
| Surplus Reserve |
59,041,488.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-64,161,547.07 |
| Minority Stockholder's Interest |
2,091,063.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
630,833,968.31 |
| Owner's Equity（Stockholder's Equity） |
632,925,031.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
674,685,108.24 |
